Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson L Michael

Showing results (251-260 of 372) with videos related to

Pageof 38
Sort By:
Science Translational Medicine|March 21, 2014
Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccinesAmy W Chung, Musie Ghebremichael, Hannah Robinson, et al.
Military Medicine|September 1, 2012
An investigation of bloodborne pathogen transmission due to multipatient sharing of insulin pensShilpa Hakre, Donna R Upshaw-Combs, Eric E Sanders-Buell, et al.
Transfusion|October 16, 2010
Transfusion-transmissible viral infections among US military recipients of whole blood and platelets during Operation Enduring Freedom and Operation Iraqi FreedomShilpa Hakre, Sheila A Peel, Robert J O'Connell, et al.
Plos Pathogens|August 4, 2017
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaquesMichael K McCracken, Gregory D Gromowski, Heather L Friberg, et al.
The Journal of Clinical Investigation|February 5, 2020
Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruptionJulie L Mitchell, Hiroshi Takata, Roshell Muir, et al.
Lancet (London, England)|December 27, 2014
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trialHannah Kibuuka, Nina M Berkowitz, Monica Millard, et al.
NPJ Vaccines|May 18, 2022
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaquesJohn D Ventura, Joseph P Nkolola, Abishek Chandrashekar, et al.
Plos Computational Biology|February 1, 2021
Factors influencing estimates of HIV-1 infection timing using BEASTBethany Dearlove, Sodsai Tovanabutra, Christopher L Owen, et al.
Medicine|August 12, 2016
Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AGRichard A Heipertz, Ojor Ayemoba, Eric Sanders-Buell, et al.
Nature|January 6, 2012
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysDan H Barouch, Jinyan Liu, Hualin Li, et al.
Pageof 38

Showing results (251-260 of 372) with videos related to

Sort By:
Pageof 38
Science Translational Medicine|March 21, 2014
Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccinesAmy W Chung, Musie Ghebremichael, Hannah Robinson, et al.
Military Medicine|September 1, 2012
An investigation of bloodborne pathogen transmission due to multipatient sharing of insulin pensShilpa Hakre, Donna R Upshaw-Combs, Eric E Sanders-Buell, et al.
Transfusion|October 16, 2010
Transfusion-transmissible viral infections among US military recipients of whole blood and platelets during Operation Enduring Freedom and Operation Iraqi FreedomShilpa Hakre, Sheila A Peel, Robert J O'Connell, et al.
Plos Pathogens|August 4, 2017
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaquesMichael K McCracken, Gregory D Gromowski, Heather L Friberg, et al.
The Journal of Clinical Investigation|February 5, 2020
Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruptionJulie L Mitchell, Hiroshi Takata, Roshell Muir, et al.
Lancet (London, England)|December 27, 2014
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trialHannah Kibuuka, Nina M Berkowitz, Monica Millard, et al.
NPJ Vaccines|May 18, 2022
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaquesJohn D Ventura, Joseph P Nkolola, Abishek Chandrashekar, et al.
Plos Computational Biology|February 1, 2021
Factors influencing estimates of HIV-1 infection timing using BEASTBethany Dearlove, Sodsai Tovanabutra, Christopher L Owen, et al.
Medicine|August 12, 2016
Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AGRichard A Heipertz, Ojor Ayemoba, Eric Sanders-Buell, et al.
Nature|January 6, 2012
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysDan H Barouch, Jinyan Liu, Hualin Li, et al.
Pageof 38